Multiple Coronavirus Vaccines Is Policy Aim, But Will Complicate Supply Chain

At Senate hearing, FDA and NIH officials say government and vaccine developers are outlining production needs with ability to shift manufacturing from their candidates to others to ensure production of the most promising products. FDA Commissioner Hahn says as an essential worker he would break quarantine if needed at a critical White House or other meeting.

Senators and staffers practice social distancing and wear masks during HELP's coronavirus hearing on 12 May 2020
Senators and staffers practice social distancing and wear masks during HELP's coronavirus hearing on 12 May 2020. • Source: Screenshot of Senate webcast

US Food and Drug Administration Commissioner Stephen Hahn reiterated the federal government’s intent in helping develop multiple coronavirus vaccines, even though it may create challenges for the supply chain.

Hahn said during a 12 May Senate Health, Education, Labor and Pensions Committee hearing that the agency is committed to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet